IVZ Stock Analysis: Buy, Sell, or Hold?
IVZ - Invesco LTD
$23.25
0.05 (0.22%)
▲
5d:
-2.19%
30d:
-11.46%
90d:
-13.76%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 28, 2026
28d
Smart Money Accumulation
IVZ is down 3.6% this week, but smart money is accumulating calls. Top strike: $31 2026-04-17 with 8,191 OI. Call ratio: 78% View Scanner →
Strength: 4.6/10
Get Alerted When IVZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IVZ appears deeply undervalued. Market expects -6.6% annual earnings decline despite 450% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: IVZ appears deeply undervalued. Market expects -6.6% annual earnings decline despite 450% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.46
Based on 8.9% avg growth
INTRINSIC VALUE TODAY
$26.99
13.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IVZ is currently trading at $23.25, which is considered slightly low relative to its 30-day fair value range of $23.24 to $25.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.7) compared to its historical average (9.4). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This pessimistic expectation contrasts with the company's recent 450.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IVZ is in a strong uptrend. The price is currently testing key support at $22.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.86 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IVZ is in a strong uptrend. The price is currently testing key support at $22.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.86 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$23.24 -
$25.82
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.7% below Wall St target ($29.86)
Fair Price Analysis
30-Day Fair Range
$23.24 -
$25.82
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$22.80
Resistance Level
$24.60
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.65
Wall Street Target
$29.86
(+28.7%)
Revenue Growth (YoY)
6.2%
Earnings Growth (YoY)
450.0%
Profit Margin
-4.4%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
7.7 vs 9.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$21.67
(-7%)
2-Year Target
$20.24
(-13%)
3-Year Target
$18.90
(-19%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$23.23
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 13.7%)
$99.95
(+331%)
Base:
(SPY PE: 7.6, Growth: 13.7%)
$34.13
(+47%)
Bear:
(PE: 6.5, Growth: 13.7%)
$29.01
(+25%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.6 to 9.4
Stabilization Target:
$28.51
(+22.9%)
PE Expansion Potential:
+22.9%
Share & Embed Analysis
Last updated: March 30, 2026 1:38 PM ET
Data refreshes hourly during market hours. Next update: 2:38 PM
Data refreshes hourly during market hours. Next update: 2:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVZ showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-02-10
Gilbert Ray Cisneros, Jr.
BUY
2026-01-09
Douglas J Sharp
SELL
160000 shares
2025-10-31
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KKR
KKR & Co LP |
STRONG BUY
21 analysts |
$137 | 56 HOLD |
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1321 | 57 HOLD |
|
APO
Apollo Global Management… |
STRONG BUY
19 analysts |
$155 | 61 BUY |
|
HASI
Hannon Armstrong Sustain… |
STRONG BUY
16 analysts |
$44 | 62 BUY |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$159 | 60 HOLD |
Advanced IVZ Option Strategies
Professional options setups generated by AI based on today's IVZ price and gamma walls.
